← All organizations
Highest phase reached
Phase 2
First clinical trial
Jun 29, 2022Last known activity
Aug 1, 2024
Timeline
2010s
- Jan 1, 2016
EyebioKorea, Inc.— Founded
Drugs by trial phase (1 distinct, 2 trials)
Phase 2 (1 own, 0 via acquisition)
Recent trials (2)
- NCT06487039Lead sponsorPhase 2Aug 1, 2024
- NCT05538949Lead sponsorPhase 1Jun 29, 2022
Details
- Founded
- Busan, KR Jan 1, 2016
- Last known activity
- Aug 1, 2024